Recent investigations have focused on the convergence of GLP-1|glucose-dependent insulinotropic polypeptide|glucagon receptor activator therapies and dopamine communication. While GLP stimulators are widely employed for treating type 2 diabetes, their potential effects on motivation circuits, spe